Variant report

Variant	nsv498958
Chromosome Location	chr2:234648331-234660024
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234653876-234654428	HepG2	liver:	n/a	n/a
2	ATF3	chr2:234653988-234654486	A549	lung:	n/a	n/a
3	BCL3	chr2:234653958-234654499	A549	lung:	n/a	n/a
4	BCL3	chr2:234653885-234654544	A549	lung:	n/a	n/a
5	BHLHE40	chr2:234654058-234654451	HepG2	liver:	n/a	n/a
6	CBX3	chr2:234659353-234659614	K562	blood:	n/a	n/a
7	CEBPB	chr2:234653979-234654335	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
8	CEBPB	chr2:234653943-234654318	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
9	CEBPB	chr2:234656934-234657289	HepG2	liver:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
10	CEBPB	chr2:234657008-234657264	IMR90	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
11	CEBPB	chr2:234656935-234657273	A549	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
12	CEBPB	chr2:234653902-234654598	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
13	CEBPB	chr2:234653908-234654385	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
14	CEBPB	chr2:234654020-234654389	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
15	CEBPB	chr2:234653961-234654410	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
16	CEBPB	chr2:234653892-234654497	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
17	CEBPD	chr2:234654049-234654478	HepG2	liver:	n/a	n/a
18	CHD2	chr2:234654164-234654273	HepG2	liver:	n/a	n/a
19	CREB1	chr2:234654194-234654509	A549	lung:	n/a	n/a
20	CREB1	chr2:234653888-234654608	HepG2	liver:	n/a	n/a
21	CREB1	chr2:234654062-234654459	A549	lung:	n/a	n/a
22	CREB1	chr2:234653968-234654547	HepG2	liver:	n/a	n/a
23	CTCF	chr2:234651938-234652009	GM20000	blood:	n/a	n/a
24	CTCF	chr2:234651956-234652041	Kidney_OC	kidney:	n/a	n/a
25	EP300	chr2:234653868-234654574	HepG2	liver:	n/a	chr2:234654068-234654082
26	EP300	chr2:234653933-234654548	HepG2	liver:	n/a	chr2:234654068-234654082
27	EP300	chr2:234654030-234654453	HepG2	liver:	n/a	chr2:234654068-234654082
28	EP300	chr2:234653810-234654542	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
29	EP300	chr2:234653700-234654700	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
30	FOSL2	chr2:234654004-234654404	A549	lung:	n/a	n/a
31	FOSL2	chr2:234654000-234654628	HepG2	liver:	n/a	n/a
32	FOSL2	chr2:234653860-234654613	A549	lung:	n/a	n/a
33	FOSL2	chr2:234653946-234654485	HepG2	liver:	n/a	n/a
34	FOXA1	chr2:234653830-234654570	HepG2	liver:	n/a	n/a
35	FOXA1	chr2:234653527-234654585	HepG2	liver:	n/a	n/a
36	FOXA1	chr2:234653906-234654589	HepG2	liver:	n/a	n/a
37	FOXA1	chr2:234653871-234654608	HepG2	liver:	n/a	n/a
38	FOXA2	chr2:234653954-234654644	A549	lung:	n/a	n/a
39	FOXA2	chr2:234653696-234654749	HepG2	liver:	n/a	n/a
40	FOXA2	chr2:234653649-234654629	A549	lung:	n/a	n/a
41	FOXA2	chr2:234653884-234654483	HepG2	liver:	n/a	n/a
42	GATA3	chr2:234653893-234654633	A549	lung:	n/a	n/a
43	GATA3	chr2:234653885-234654644	A549	lung:	n/a	n/a
44	HDAC2	chr2:234653902-234654531	HepG2	liver:	n/a	n/a
45	HDAC2	chr2:234653853-234654551	HepG2	liver:	n/a	n/a
46	HEY1	chr2:234652495-234652743	K562	blood:	n/a	n/a
47	HNF4A	chr2:234653907-234654493	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
48	HNF4A	chr2:234653992-234654483	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
49	HNF4A	chr2:234654029-234654486	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
50	HNF4G	chr2:234653874-234654479	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654285-234654298

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234651850-234651900	AG10803	skin:	n/a
2	chr2:234651850-234651900	AG10803	skin:	n/a
3	chr2:234652681-234652731	BJ	skin:	n/a
4	chr2:234650765-234650815	HUVEC	blood vessel:	n/a
5	chr2:234650765-234650815	HCM	heart:	n/a
6	chr2:234652363-234652413	LNCaP	prostate:	n/a
7	chr2:234655709-234655759	Hela-S3	cervix:	n/a
8	chr2:234653891-234653941	NHBE	bronchial:	n/a
9	chr2:234652601-234652651	GM12878	blood:	n/a
10	chr2:234649204-234649254	NHBE	bronchial:	n/a
11	chr2:234652601-234652651	IMR90	lung:	fetal
12	chr2:234652363-234652413	SK-N-MC	brain:	n/a
13	chr2:234652681-234652731	MCF-7	breast:	n/a
14	chr2:234650765-234650815	A549	lung:	n/a
15	chr2:234652466-234652516	SK-N-SH	brain:	n/a
16	chr2:234652601-234652651	BJ	skin:	n/a
17	chr2:234650765-234650815	GM06990	blood:	n/a
18	chr2:234652669-234652719	GM06990	blood:	n/a
19	chr2:234651850-234651900	MCF10A-Er-Src	breast:	n/a
20	chr2:234651850-234651900	MCF-7	breast:	n/a
21	chr2:234655709-234655759	MCF-7	breast:	n/a
22	chr2:234651850-234651900	NB4	blood:	n/a
23	chr2:234652466-234652516	ECC-1	luminal epithelium:	n/a
24	chr2:234652681-234652731	RPTEC	kidney:	n/a
25	chr2:234651850-234651900	NHBE	bronchial:	n/a
26	chr2:234651850-234651900	Jurkat	blood:	n/a
27	chr2:234651850-234651900	CMK	blood:	n/a
28	chr2:234652601-234652651	MCF10A-Er-Src	breast:	n/a
29	chr2:234650765-234650815	HNPCEpiC	eye:	n/a
30	chr2:234652601-234652651	GM06990	blood:	n/a
31	chr2:234652669-234652719	BE2_C	brain:	n/a
32	chr2:234652669-234652719	AG09319	gingival:	n/a
33	chr2:234652466-234652516	IMR90	lung:	fetal
34	chr2:234652669-234652719	NHBE	bronchial:	n/a
35	chr2:234649204-234649254	AG04450	lung:	fetal
36	chr2:234652601-234652651	HRE	kidney:	n/a
37	chr2:234652601-234652651	ProgFib	skin:	n/a
38	chr2:234653891-234653941	ECC-1	luminal epithelium:	n/a
39	chr2:234652601-234652651	HEK293	kidney:	embryo
40	chr2:234652669-234652719	HL-60	blood:	n/a
41	chr2:234652601-234652651	Caco-2	colon:	n/a
42	chr2:234652681-234652731	GM12891	blood:	n/a
43	chr2:234652669-234652719	SK-N-SH	brain:	n/a
44	chr2:234653891-234653941	HRE	kidney:	n/a
45	chr2:234653891-234653941	NHDF-neo	bronchial:	n/a
46	chr2:234652363-234652413	MCF10A-Er-Src	breast:	n/a
47	chr2:234652601-234652651	HRPEpiC	eye:	n/a
48	chr2:234649204-234649254	HCPEpiC	choroid plexus:	n/a
49	chr2:234653891-234653941	H1-hESC	embryonic stem cell:	embryo
50	chr2:234653891-234653941	HRCEpiC	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:234650134..234652973-chr2:234653062..234655371,2	MCF-7	breast:
2	chr17:63274126..63274957-chr2:234657055..234657979,2	MCF-7	breast:
3	chr2:234651385..234654197-chr2:234659573..234662296,2	MCF-7	breast:
4	2:234543708-234558325..2:234649753-234657866	Hela-S3	cervix:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT1A1-1	chr2:234659263-234659366	NONHSAT077510
2	lnc-UGT1A1-2	chr2:234649334-234649521	NONHSAT077507
3	lnc-UGT1A1-2	chr2:234650166-234650603	NONHSAT077507

Variant related genes	Relation type
UGT1A2P	TF binding region
ENSG00000248705	TF binding region
DNAJB3	TF binding region
UGT1A2P	CpG island
ENSG00000248705	CpG island
DNAJB3	CpG island
ENSG00000234143	chromatin interactions
ENSG00000227802	chromatin interactions
ENSG00000242515	chromatin interactions

Extended variants
information (count: 606 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:606 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs558118355	chr2:234648332-234648333	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs578128950	chr2:234648354-234648355	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs193084224	chr2:234648367-234648368	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs183557056	chr2:234648380-234648381	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs186719753	chr2:234648385-234648386	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs541880710	chr2:234648386-234648387	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs11695770	chr2:234648452-234648453	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs527239626	chr2:234648453-234648454	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs146148074	chr2:234648463-234648464	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs555368732	chr2:234648466-234648467	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs371090743	chr2:234648491-234648492	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs28900070	chr2:234648515-234648516	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs28900071	chr2:234648523-234648524	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs370697859	chr2:234648550-234648551	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs572345956	chr2:234648555-234648556	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs28900072	chr2:234648559-234648560	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs28900073	chr2:234648568-234648569	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs143578493	chr2:234648583-234648584	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs533176233	chr2:234648597-234648598	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs28900075	chr2:234648600-234648601	Weak transcription Strong transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs28900076	chr2:234648607-234648608	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs374219817	chr2:234648620-234648621	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs28900077	chr2:234648629-234648630	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs28899768	chr2:234648639-234648640	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs28899769	chr2:234648659-234648660	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs370068879	chr2:234648685-234648686	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs374549434	chr2:234648691-234648692	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs368597738	chr2:234648698-234648699	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs6740653	chr2:234648708-234648709	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs375117222	chr2:234648727-234648728	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs17862874	chr2:234648746-234648747	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs143794870	chr2:234648780-234648781	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs565737138	chr2:234648790-234648791	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs534667918	chr2:234648797-234648798	Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs578012287	chr2:234648802-234648803	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs571818278	chr2:234648805-234648806	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs537677937	chr2:234648814-234648815	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs191572005	chr2:234648816-234648817	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs573081380	chr2:234648832-234648833	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs543664272	chr2:234648838-234648839	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs2018985	chr2:234648860-234648861	Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs183860423	chr2:234648866-234648867	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs6746419	chr2:234648883-234648884	Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs540642726	chr2:234648910-234648911	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs564436017	chr2:234648948-234648949	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs533064296	chr2:234648977-234648978	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs543256832	chr2:234649022-234649023	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs542925034	chr2:234649122-234649123	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs567256454	chr2:234649133-234649134	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs529004725	chr2:234649154-234649155	Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Pancreatic cancer	17952125	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:63 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234620400-234659200	Weak transcription	Colonic Mucosa	Colon
2	chr2:234620600-234652200	Weak transcription	Esophagus	oesophagus
3	chr2:234626200-234649600	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr2:234626600-234668400	Weak transcription	NHEK	skin
5	chr2:234634600-234648400	Weak transcription	A549	lung
6	chr2:234645400-234648600	Enhancers	Liver	Liver
7	chr2:234646400-234648800	Bivalent Enhancer	HepG2	liver
8	chr2:234646400-234651000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
9	chr2:234646400-234666600	Weak transcription	Stomach Mucosa	stomach
10	chr2:234647000-234648400	Enhancers	Fetal Intestine Large	intestine
11	chr2:234647800-234652200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr2:234647800-234655000	Weak transcription	Gastric	stomach
13	chr2:234648000-234648600	Enhancers	Duodenum Mucosa	Duodenum
14	chr2:234648000-234649800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr2:234648400-234648600	Enhancers	A549	lung
16	chr2:234648600-234649200	Weak transcription	Duodenum Mucosa	Duodenum
17	chr2:234648600-234649200	Weak transcription	A549	lung
18	chr2:234648600-234650400	Weak transcription	Liver	Liver
19	chr2:234649600-234649800	Enhancers	Rectal Mucosa Donor 29	rectum
20	chr2:234649800-234652200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
21	chr2:234649800-234658800	Weak transcription	Rectal Mucosa Donor 29	rectum
22	chr2:234650400-234652600	Genic enhancers	Liver	Liver
23	chr2:234651000-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr2:234652200-234652600	ZNF genes & repeats	Esophagus	oesophagus
27	chr2:234652200-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
28	chr2:234652400-234652600	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr2:234652600-234654400	Enhancers	Liver	Liver
30	chr2:234652600-234654600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr2:234652800-234658200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr2:234652800-234659200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr2:234653200-234654400	Enhancers	HepG2	liver
34	chr2:234653200-234655600	Enhancers	Fetal Intestine Small	intestine
35	chr2:234653400-234653800	Enhancers	A549	lung
36	chr2:234653800-234654200	Active TSS	A549	lung
37	chr2:234654200-234654800	Enhancers	Small Intestine	intestine
38	chr2:234654200-234655000	Enhancers	A549	lung
39	chr2:234654200-234655400	Enhancers	Duodenum Mucosa	Duodenum
40	chr2:234654200-234655400	Enhancers	Fetal Intestine Large	intestine
41	chr2:234654400-234654600	Flanking Active TSS	HepG2	liver
42	chr2:234654400-234656000	Flanking Active TSS	Liver	Liver
43	chr2:234654600-234655800	Bivalent Enhancer	HepG2	liver
44	chr2:234655000-234655200	Flanking Active TSS	A549	lung
45	chr2:234655000-234655600	Enhancers	Gastric	stomach
46	chr2:234655200-234655400	Enhancers	A549	lung
47	chr2:234655400-234655600	Flanking Active TSS	A549	lung
48	chr2:234655400-234656200	Enhancers	Pancreas	Pancrea
49	chr2:234655600-234656200	Enhancers	A549	lung
50	chr2:234656000-234656600	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links